Product Information
JENTADUETO XR 2.5 MG-1,000 MG is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $8.4718 per EA under NDC 00597027094. Its NADAC has been published 470 times since Aug 23, 2017.
FDA first approved this application on May 27, 2016.
Strength
2.5; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597027094
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208026FDA Approved
5/27/2016
On Market Since
5/27/2016
Pharmacological Classes
Price Statistics
The NADAC for JENTADUETO XR 2.5 MG-1,000 MG has been published 470 times since Aug 23, 2017, and over the history we have for it it has risen 38.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4718 per EA |
|---|---|
| All-time high | $8.4718 (Aug 19, 2026) |
| All-time low | $6.1336 (Aug 23, 2017) |
| 52-week high | $8.4718 |
| 52-week low | $8.4439 |
| Median price | $8.0796 |
| Average price | $7.7400 |
| Largest weekly change | +8.0% (Jan 10, 2018) |
| Weeks tracked | 470 |
| Tracking since | Aug 23, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of JENTADUETO XR 2.5 MG-1,000 MG?
The current National Average Drug Acquisition Cost (NADAC) for JENTADUETO XR 2.5 MG-1,000 MG, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $8.4718 per EA (NDC 00597027094), effective Aug 19, 2026.
How has the price of JENTADUETO XR 2.5 MG-1,000 MG changed over time?
Over the history we have for it, the NADAC for JENTADUETO XR 2.5 MG-1,000 MG has risen 38.1%. It has been tracked across 470 weekly CMS publications since Aug 23, 2017.
What are the highest and lowest recorded NADAC prices for JENTADUETO XR 2.5 MG-1,000 MG?
Since Aug 23, 2017, the NADAC for JENTADUETO XR 2.5 MG-1,000 MG has ranged from a low of $6.1336 (Aug 23, 2017) to a high of $8.4718 (Aug 19, 2026), with a median of $8.0796 per EA.
Are there cheaper alternatives to JENTADUETO XR 2.5 MG-1,000 MG?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JENTADUETO 2.5 MG-1,000 MG TAB, is $8.4395 per EA — about 0% below JENTADUETO XR 2.5 MG-1,000 MG.
Who manufactures JENTADUETO XR 2.5 MG-1,000 MG?
JENTADUETO XR 2.5 MG-1,000 MG (NDC 00597027094) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.